NeoGenomics (NEO) Tmuɣli n wazal
NeoGenomics
Ṛṛbem n lḥedd$19.33Yettwalemmaḍ 25 Sep 2026 19:59 UTC
Beddel-1.23%
Asnulfu n AI: NEO
AI tessawal ɣef timaqsiṭ n wazal i wass n tnekkit d-iteddun, taggara n yimal akked taggara n waggʷas. Asnifel yettwamḍen seg wazal aneggaru. Aya d tinineḍ n tḥisabt, ma tga ara timsisi n usihel.
Asref n 6 isggʷasn ineggura
Premium tessaɣ-d iswiyat n tɣara n AI i wass, amalas d waggʷas n yiwen i uḍris-a akk d yisɣunan niḍen.
Serreḥ Premium🔒 Tazmilt n usenfar
Amezruy n tmuɣliyin — akk tmuɣliyin n zik akked wazal n tnekkit — d akcum n Premium.
Serreḥ PremiumƔef tneɣlaft-a
NeoGenomics, Inc. operates a network of clinical laboratories specializing in diagnostic testing for hereditary cancer. The company’s services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, morphology, anatomic pathology, and molecular genetic testing.
